Amantadine and interferon for treatment of chronic hepatitis C - A preliminary analysis.

被引：0
|
作者：
Ben-Ari, Z
Zemel, R
Kazatzker, A
Manhaim, V
Tur-Kaspa, R
机构：
[1] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
[2] Felsenstein Med Res Ctr, Petah Tiqwa, Israel
[3] Rabin Med Ctr, Dept Med D, Liver Inst, Petah Tiqwa, Israel
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2136
引用
收藏
页码：696A / 696A
页数：1
相关论文
共 50 条
  • [41] Treatment with amantadine plus ribavirin plus interferon in patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy.
    Ferenci, P
    Stauber, R
    Hackl, F
    Schuetze, K
    Bauer, B
    Datz, C
    GASTROENTEROLOGY, 2000, 118 (04) : A1437 - A1437
  • [42] Treatment of chronic hepatitis C with amantadine hydrochloride in patients who had not responded to previous treatment with interferon-α and/or ribavirin
    Di Martino, V
    Boudjema, H
    Delacour, T
    Cazier, A
    Caron, C
    Coutarel, P
    Dumouchel, P
    Cadranel, JF
    CLINICAL INFECTIOUS DISEASES, 2001, 32 (05) : 830 - 831
  • [43] Pegylated-interferon and ribavirin for recurrent hepatitis C after liver transplantation - A preliminary analysis.
    Mukherjee, S
    Gilroy, RK
    McCashland, TM
    Schafer, DF
    Zetterman, RK
    Sorrell, MF
    HEPATOLOGY, 2002, 36 (04) : 184A - 184A
  • [44] Pegylated interferon, ribavirin and amantadine for treatment of chronic hepatitis C: A multi-center clinical trial.
    Younossi, ZM
    McCullough, AJ
    Barnes, DS
    Post, A
    Ong, JP
    Mullen, KD
    Carey, WD
    O'Shea, R
    Levinthal, G
    Gramlich, T
    Martin, L
    Bringman, D
    Tavill, AS
    Ferguson, DR
    HEPATOLOGY, 2002, 36 (04) : 603A - 603A
  • [45] Treatment of patients with chronic hepatitis C with interferon-alpha (IFN-alpha) combined with amantadine.
    Matzner, T
    Wechsler, JG
    Schulz, B
    Ott, B
    Grund, A
    HEPATOLOGY, 2001, 34 (04) : 585A - 585A
  • [46] Usefulness of erythropoietin and G-CSF during treatment for chronic hepatitis C with pegylated interferon: A clinical descriptive analysis.
    Lebray, P
    Pichard, AV
    Broissand, C
    Nalpas, B
    Sobesky, R
    Fontaine, H
    Pol, S
    HEPATOLOGY, 2002, 36 (04) : 574A - 574A
  • [47] Interferon-α plus amantadine in chronic hepatitis C resistant to interferon alone:: a pilot randomized study
    Gaeta, GB
    Stornaiuolo, G
    Stanzione, M
    Ascione, T
    Pasquazzi, C
    Taliani, G
    Cimino, L
    Budillon, G
    Piccinino, F
    JOURNAL OF VIRAL HEPATITIS, 2001, 8 (04) : 284 - 286
  • [48] Evaluation of amantadine in chronic hepatitis C: A meta-analysis.
    Deltenre, P
    Henrion, J
    Canva, V
    Texier, F
    Louvet, A
    de Maeght, S
    Paris, JC
    Mathurin, P
    HEPATOLOGY, 2004, 40 (04) : 386A - 387A
  • [49] Evaluation of amantadine in chronic hepatitis C: a meta-analysis
    Deltenre, P
    Henrion, J
    Canva, V
    Dharancy, S
    Texier, F
    Louvet, A
    De Maeght, S
    Paris, JC
    Mathurin, P
    JOURNAL OF HEPATOLOGY, 2004, 41 (03) : 462 - 473
  • [50] Interferon treatment of children with chronic hepatitis C
    Al-Tawil, Y
    Nelson, C
    HEPATO-GASTROENTEROLOGY, 1998, 45 (20) : 345 - 348
12345